European Movers: GSK (GSK LN) +2%, Pernod Ricard (RI FP) +1.5%, Euronext (ENX FP) +1.2%, AstraZeneca (AZN LN) +1%, Stellantis (STLAM IM/STLAP FP) -1.2%, ASML (ASML NA) -4%

The composition here splits along familiar lines: large-cap pharma bid on the upside alongside a beverage name, while the heaviest single loss sits in semiconductors, a sector where outsized one-day swings have historically tracked order-book commentary, export-control headlines, or read-across from a US peer rather than anything domestic. Pharma strength in heavyweights of this size has tended to flow directly into the UK and broader European indices given index weightings, whereas a single-digit decline in a bellwether chip name has on past occasions dragged the whole equipment peer set with it. The useful follow-ons are the underlying catalysts, whether broker notes, earnings, or sector news, and whether the semiconductor weakness is company-specific or confirms across the equipment complex. Absent the body copy, the note can only flag the pattern, not the cause.